Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Eye Atlas: A Key to Novel Eye Disease Therapies
Glaucoma and macular degeneration result in blindness for millions of people every year. These diseases have been linked to hundreds of genes that increase susceptibility, often serving as initial targets for therapies aimed at preventing or reversing blindness. However, the…
Pros and Cons of Laser Surgery for Glaucoma Patients
Glaucoma is a complex eye condition characterized by increased intraocular pressure, which can lead to damage to the optic nerve and vision loss if left untreated. This group of eye disorders often develops without noticeable symptoms in its early stages,…
Anterior Uveitis: Causes, Symptoms and Treatment
Picture this: You’re an astronaut on a space mission, and you’ve just stepped out of your spacecraft onto the surface of a mysterious new planet. Your eyesight is crucial to your survival in this alien environment, as you must rely…
Retinal Vascular Occlusion: Causes and Treatments
Have you ever wondered about the intricate network of blood vessels that sustains our vision? Behind the captivating scenes of our visual perception lies a delicate system vulnerable to a formidable adversary known as retinal vascular occlusion. This menacing condition,…
Glaucoma Eye Drops List You Need for IOP Management
Glaucoma, a group of eye conditions that damage the optic nerve, is often linked to an increase in intraocular pressure (IOP). Managing IOP is crucial in glaucoma treatment to prevent vision loss. Eye drops play a vital role in this…
What Is Pseudoexfoliation Syndrome? | OBN
Pseudoexfoliation syndrome (PEX) is a systemic disorder characterized by the abnormal production and accumulation of fibrous extracellular material in various parts of the body, including the eyes. This condition is most commonly known for its impact on ocular health, where…
Glaucoma Cell Replacement Therapy to Reverse Vision Loss |OBN
Glaucoma, a leading global cause of blindness, results in irreversible vision loss due to the depletion of retinal ganglion cells (RGCs), which cannot currently be reversed with any treatment. While certain studies explore RGC replacement through cell transplants, this approach…
The Connection Between Antidepressants and Glaucoma
Amidst the intricate interplay of medical conditions and their treatments, unexpected relationships sometimes emerge. One such intriguing link has been proposed between antidepressant use and the risk of glaucoma. As two conditions seemingly distinct, depression and glaucoma occupy different corners…
Bausch + Lomb Launches ‘Faces of Glaucoma’ Campaign
Bausch + Lomb and the Glaucoma Research Foundation (GRF) have introduced the “Faces of Glaucoma” campaign, aiming to showcase a variety of patient stories and enhance awareness about the global issue of glaucoma, the second leading cause of blindness. This…
SpyGlass Pharma Secures $90M in Funding
SpyGlass Pharma has successfully closed a Series C financing round, raising $90 million. RA Capital Management led the funding round, joined by existing investors New Enterprise Associates (NEA) and Vensana Capital, as well as new investors Samsara BioCapital and Vertex…